Stay updated on Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page.

Latest updates to the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check22 days agoChange DetectedA banner announces that NIH websites are transitioning to use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with links to updates and FAQs.SummaryDifference0.5%

- Check29 days agoChange DetectedThe website footer now displays release revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check36 days agoChange DetectedThe footer’s ClinicalTrials.gov site revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check56 days agoChange DetectedThe study's history gains a new Revision: v3.7.0 entry, indicating a newer page version. The previous Revision: v3.6.6 entry appears to be superseded in the history.SummaryDifference0.1%

- Check78 days agoChange DetectedAdded a new revision entry showing Revision: v3.6.6 in the version history. The previous Revision: v3.6.5 entry was removed, updating the study record's history log.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page.